Skip to content

Clinical Observation on Electroacupuncture in the Treatment of Elderly Patients with aMCI of Marrow Vacuity and Phlegm Turbidity Type: A Randomized Clinical Trial

Clinical Observation on Electroacupuncture in the Treatment of Elderly Patients with aMCI of Marrow Vacuity and Phlegm Turbidity Type: A Randomized Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000604
Enrollment
Unknown
Registered
2026-03-18
Start date
2026-03-09
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amnestic mild cognitive impairment

Interventions

Electroacupuncture group:Electroacupuncture (acupuncture points: Baihui (GV20), Neiguan (PC6), etc., balanced reinforcing-reducing technique, connect to the electroacupuncture device upon obtaining Qi
Waiting Treatment Group:The observation period consists of only twice weekly finger exercises, each lasting 10-15 minutes. Following the observation period, 8 weeks of electroacupuncture treatment wil

Sponsors

Affiliated Hospital of Shaanxi University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meets the diagnostic criteria for mild cognitive impairment in Western medicine and the diagnostic criteria for the type of "spleen deficiency with phlegm obstruction" in traditional Chinese medicine; 2. Aged between 40 and 80 years (inclusive of 40 and 80), with no restriction on gender; 3. Right-handed, without visual or auditory impairments, and able to cooperate with scale assessments; 4. Has not participated in other clinical studies in the past 3 months, has not been on long-term specific medications prior to enrollment, or has completed the washout period; 5. Voluntarily participates in the study and signs the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Organic diseases that can explain cognitive impairment; 2. Alarm symptoms or long-term use of non-steroidal drugs; 3. Cognitive impairment caused by a clear underlying cause; 4. Severe aphasia or neurological deficits, making cognitive assessment impossible; 5. Diagnosed with other types of dementia; 6. History of alcoholism, drug abuse, or misuse of psychiatric medications; 7. Allergy to acupuncture or severe coagulation disorders.

Design outcomes

Primary

MeasureTime frame
Alzheimer's Disease Assessment Scale-Cognitive Subscale;

Secondary

MeasureTime frame
Montreal Cognitive Assessment Scale;Mini-Mental State Examination (MMSE) Scale Score;Activities of Daily Living Scale Scoring;Pittsburgh Sleep Quality Index Scale/;

Countries

China

Contacts

Public ContactDiwu Yongchang

Shaanxi University of Chinese Medicine

diwuyongchang@126.com13629189161

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Apr 4, 2026